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The Recruitment of monocytes to the pre-ovulatory ovary
Alex Whitaker
Ovulation is a recurring biological process that involves inflammatory reactions that
degrade and restructure tissue. It requires the chemotaxis of leukocytes to the ovary to
help regulate and promote these events. Hormonal signals and chemokines that are
released during the peri-ovulatory period initiate the release of specific leukocyte
populations, possibly from the spleen, that infiltrate the ovary and facilitate the release of
oocytes from ovarian follicles. These studies utilized a super-ovulation protocol to
initiate ovulation in immature balb/c and cd1 mice. Ovaries were collected at several
times post human chorionic gonadotropin (hCG) injection and analyzed by multi-color
flow cytometry. Oviducts were collected from mice 20 hours after hCG administration
and cumulous oocyte complexes were collected, counted and averaged to determine
ovulation rate. Immunohistochemistry was used to determine the location of specific cell
types in the ovary. We identified a specific population of monocytes, deemed ly6𝑐 ℎ𝑖𝑔ℎ
monocytes, which infiltrate the ovary at a specific time. Immediately before ovulation
occurs, ly6𝑐 ℎ𝑖𝑔ℎ monocytes are found in increased numbers in the ovaries, possibly to
promote inflammation and follicular rupture. After ovulation, the numbers of these
monocytes decreases rapidly, likely because once they enter the tissues they differentiate
into either M1 macrophages, to further promote inflammation, or M2 macrophages to
stimulate corpus luteum development. Studies have shown that animals deficient of these
subsets of monocytes and macrophages have reduced rates of ovulation. Several other
leukocyte populations were identified infiltrating the ovary, suggesting multiple
leukocyte subsets are involved in ovulation. In this regard, in the ovary, the
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ly6𝑐 ℎ𝑖𝑔ℎ monocytes may function as a source of M1 and M2 macrophages that initiate the
inflammatory process and facilitate the rest of the reproductive process.
Keywords: flow cytometry, neutrophil, Ly6𝑐 ℎ𝑖𝑔ℎ monocyte, macrophage, ovulation
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Chapter 1
Introduction
Ovulation
In many women, ovulation is a naturally occurring, monthly inflammatory
process that results in the release of an oocyte for possible fertilization. Ovulation is
brought about by many physiological changes, such as fluctuations in hormonal levels
and cell signaling1. These changes cause different types and numbers of white blood
cells to migrate to the ovaries to ensure ovulation occurs successfully2. Specifically, the
types of white blood cells found in follicular fluid include granulocytes, lymphocytes,
monocytes and macrophages2. It has also been reported that macrophages, neutrophils,
eosinophils and mast cells are recruited to the theca layer of follicles3,4. These cells are
recruited to very specific areas in the ovaries, namely directly to the follicle at the
boundary between the theca and granulosa cells. This infiltration, at precise points
during the ovulatory process, leads to a weakening of the follicular wall and follicular
rupture. Subsequently, the leukocytes are also critical for corpus luteum formation and
luteolysis1,5,6. In regards to ovulation, many of these inflammatory leukocytes can be
found near mature follicles, releasing products such as matrix metalloproteinases and
proteolytic enzymes that will help weaken the follicular wall, allowing oocyte release,
and helping to reorganize tissue6,7.
Without these regular alterations in physiology, the recruitment of white blood
cells is hindered, and ovulation either has a reduced success rate or does not occur,
resulting in reduced fertility and reproductive diseases such as polycystic ovarian
syndrome (PCOS)8. A genetic defect in any key component in the formation or
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recruitment of leukocytes can result in reduced ovulatory success. For example, mice
that have decreased levels of colony-stimulating factor-1, and therefore decreased
macrophage numbers, do not ovulate normally3,9. Mice that have malfunctioning
macrophages also have abnormal ovulation rates3,9. When these specific white blood cell
populations are absent, the success of ovulation can be reduced by as much as 50
percent7,9. Specific populations of white blood cells are necessary for ovulation to occur,
as they release cytokines and enzymes that help promote the inflammation at the ovarian
follicles so that they will rupture and release the oocyte, or egg cell1. After follicular
rupture, other white blood cells promote tissue repair and clean up the process of
ovulation can restart and the corpus luteum can form and be maintained6. The corpus
luteum is important in maintaining pregnancy via progesterone secretion. These
processes are able to occur because white blood cells, including monocytes and
macrophages, produce cytokines, which can recruit more white blood cells to this natural
site of inflammation as well as promote further inflammation by accumulating in large
quantities7. One of the key roles of the ovaries is steroidogenesis; the recruitment of
leukocytes to the ovary may also facilitate steroidogenesis in ovarian cells such as
granulosa-lutein cells2.
Leukocytes have been implicated as a major factor in ovulation for many reasons.
One reason to support their role is that a hindered or abnormal ovulation process appears
when leukocyte numbers are decreased or non-functioning. Many genetic defects and
immune diseases can result in incorrectly functioning white blood cells, or can cause
reduced numbers or their complete absence. In these instances, fertility issues often arise.
For example, in splenectomized mice and in osteopetrotic mice that cannot produce
2

macrophage colony-stimulating factor-1 (MCF-1), there are reduced numbers of
leukocytes and macrophages, respectively, and in both cases, pregnancy rates and litter
sizes are reduced3,6,7,9. Similarly, a mutation in the microftalmia locus causes
macrophages to malfunction, resulting in lowered ovulation success3. In individuals that
have normal leukocyte numbers and activity, their leukocyte activity or recruitment can
be blocked by various mechanisms. For instance, by using antibodies against
neutrophils, or by blocking the chemokine interleukin-8, neutrophils can be stopped from
reaching the ovary or working properly, causing ovulation to become aberrant3.
Indomethacin, which is a non-steroidal anti-inflammatory (NSAID) drug, has also been
shown to inhibit ovulation rates by hindering prostaglandin pathways and causing
abnormal follicle rupture3. Furthermore, upon being provided with adequate numbers of
normally functioning leukocytes, ovulatory rates seem to be restored. In instances where
leukocytes are abnormal through a genetic defect, the patient treated with a bone marrow
transplantation demonstrated recovered ovulation rates3,9. Lastly, leukocytes have been
implicated in playing a role in ovulation merely by their presence as well as their
products. Macrophages, monocytes, mast cells, eosinophils, and neutrophils have all
been found in ovarian tissue3. Many products of leukocytes have been observed in
ovaries during and after ovulation, including growth factors, cytokines, and chemokines,
which help recruit leukocytes to the site and promote the inflammatory process of
ovulation2,10. In fact, chemokine gene transcription has been demonstrated to be at its
highest in the ovary before ovulation takes place, indicating leukocytes are needed for
ovulation and likely for corpus luteum formation as well6.

3

The specific populations of white blood cells entering the ovaries, how they
function and how they are involved in causing ovulation has yet to be fully elucidated.
The exact source of these cells has also not been confirmed. However, it is clear that
they are integral to ovarian function including ovulation, corpus luteum formation, and
corpus luteum degradation. Once the specific populations of leukocytes involved in
successful ovulation together with the signals recruiting them to the ovary can be
identified, we will be able to better treat patients suffering from ovarian reproductive
problems.
Estrogen and Ovulation
Estrogen is one of the most influential hormones in the female body. Estrogen
occurs in three forms; estrone, estradiol, and estriol. This hormone helps regulate a
multitude of physiological processes, especially those relating to female reproduction.
Estradiol is the most potent of the three estrogen forms and predominates throughout the
fertile years of a woman’s life. Estrone predominates after menopause in women, while
estriol is the major form found during pregnancy. Estrogen has an anti-inflammatory
effect and can regulate the expression of many cell adhesion molecules on the
endothelium11. Specifically, estrogen decreases expression of adhesion molecules on the
vascular endothelium, causing it to regulate the number of leukocytes that are able to
migrate (extravasate) into the tissue11. Estrogen is also capable of suppressing key
transcription factors, such as NF-κβ. The NF-κβ pathway is involved in regulating a
multitude of immune cell genes and cytokines, as well as lowering chemokine production
of GRO3 (CXCL3), ultimately reducing recruitment of polymorphonuclear cells, such as
neutrophils11. The anti-inflammatory nature of estrogen is highlighted by the
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exacerbation of inflammatory diseases seen in women once they become postmenopausal and circulating levels of estrogen are decreased11. The drop in estrogen
levels before ovulation and the subsequent ovarian influx of leukocytes is likely a critical
signal allowing for leukocyte recruitment.
There are several hormones involved in the process of ovulation, the levels of
which fluctuate throughout the cycle. Estrogen, particularly estradiol, is one of the most
predominant hormones influencing ovulation. During the follicular phase of ovulation,
estrogen levels continuously rise until ovulation occurs. After ovulation, estrogen levels
drop sharply, and the levels of another important hormone, progesterone, rise greatly.
After ovulation occurs, the ruptured follicle forms a corpus luteum, which secretes high
levels of progesterone. If pregnancy occurs, then progesterone levels will remain high,
but levels will drop if no implantation occurs, allowing corpus luteum regression and
menstruation to occur. Progesterone plays a role in a variety of reproductive events, and
makes the uterus a hospitable environment for implantation and zygote development by
making the tissue extremely vascular. There are also two gonadotropic hormones
involved in the process of ovulation. These include follicle stimulating hormone (FSH),
which promotes the growth of immature ovarian follicles, and luteinizing hormone (LH),
which triggers ovulation and promotes the growth of the corpus luteum6. The levels of
both FSH and LH remain low until immediately before ovulation. At this point both
hormone concentrations rapidly rise, with a slight increase in FSH levels and a much
larger spike in LH levels. FSH is necessary to trigger folliculogenesis while LH plays a
more significant role in causing ovulation to occur and corpus luteum develop.
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Figure 1. Hormone fluctuation in menstrual cycle.
There are many hormones involved in the process of ovulation, which include the ovarian
hormones estradiol and progesterone, and the gonadotropins, follicle stimulating hormone and
luteinizing hormone. Day 0 through approximately 15 correlates to the follicular phase, when the
follicle grows and endometrium thickens, and day 15 through 28 corresponds to the secretory
phase, at which corpus luteum formation occurs. Ovulation occurs in between these two phases,
which is stimulated by the LH surge12. Source: Therapy Insight: preserving fertility in
cyclophosphamide-treated patients with rheumatic disease. Dooley, M. A. & Nair, R. Nature
clinical practice. Rheumatology 4, 250-257, doi:10.1038/ncprheum0770 (2008).

Follicle Development
In the ovary, there are many follicles that contain an oocyte which will go through
many changes involving growth and maturation, ovulation, corpus luteum development
and regression6. Follicles first assemble, then develop and mature, and finally ovulate;
each process is a part of folliculogenesis13. First, primordial follicles form and are
completely developed at birth, and constitute the reserve a female will have throughout
her life until they are all used, resulting in menopause14. At rest, these primordial
follicles are small and do not develop further; however when the primordial follicles
leave the reserve they will continue to mature and develop14. Primordial follicles will
grow in size and become structurally more complex as they develop into mature follicles.
6

There are varying sizes of follicles that can be grouped into three distinct classes based
on their size and complexity. Primary follicles are the smallest and consist of a growing
oocyte surrounded by a layer of cuboidal granulosa cells, which begin to express FSH
receptors14. The zona pelucida begins to form at this stage, which surrounds the oocyte.
These continue to develop and grow and can then be classified as secondary follicles,
which consists of two to ten layers of granulosa cells surrounding a fully grown oocyte
inside the zona pelucida, and a basal lamina surrounding the granulosa cells. Theca cells
also develop outside of the basal lamina at this stage of folliculogenesis, which is where
blood vessels begin to form. These blood vessels will bring the hormones necessary for
further development to the follicle. When the follicle begins to show a cavity, or antrum,
at one side of the oocyte in the granulosa cells, it is termed a tertiary follicle. When a
follicle is completely mature, there is follicular fluid in the antrum. The last step of
folliculogenesis entails ovulation, at which point the follicle ruptures and releases the
oocyte for fertilization13.
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Figure 2. An ovarian Graafian follicle.
A mature ovarian follicle with an oocyte in the center. Granulosa cells surround the oocyte. A
basement membrane separates granulosa cells from theca cells. (From Erickson GF: The ovary:
Basic principles and concepts. Source: Felig P, Baxter JD, Broadus AE, Froman LA, (eds):
Endocrinology and Metabolism. 3rd ed. New York: McGraw-Hill, 1987.

Gonadotropins and hormones play a large role in directing the development of
follicles to become preovulatory. FSH is the primary hormone stimulating follicles to
start growing15. Follicle growth begins when FSH reaches the ovary, which is detected
by receptors on granulosa cells. FSH causes granulosa cells to rapidly divide and to
express the enzyme aromatase, that cleaves testosterone into estradiol15. LH is the
second gonadotropin that plays an important role in ovulation. Theca cells, on the outer
layer of the follicle, respond to LH and will begin to produce testosterone15. Testosterone
diffuses through the basement membrane to the granulosa cells on the inner layer of the
follicle, convert it to estradiol through the enzyme aromatase15. This is all initiated by the
rush of LH reaching the ovary in the middle of the ovulation cycle15. LH also determines
which follicle is the most mature or dominant because it is detected to a greater degree by
the follicle with more LH receptors and fewer FSH receptors15. It temporarily stops all
other follicles from continuing to mature. The mid-cycle surge of LH also promotes
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granulosa cells to become luteinized after ovulation6,15. The effects of both important
gonadotropins can be mimicked by using pregnant mare serum gonadotropin (PMSG)
and human chorionic gonadotropin (hCG), which mimic FSH and LH respectively.
These two compounds are readily available to use in laboratory settings for reproductive
research.
Mature follicles that are not selected for ovulation will undergo atresia, meaning
most cells in the atretic follicle will go through apoptosis. The selected follicle will
continue to develop through ovulation, which occurs after the follicle ruptures from a
variety of proteases degrade the basal membrane2. In mice, multiple follicles will go
through this process instead of the typical single follicle ovulating in humans1. This
breakdown releases the oocyte, along with cumulous cells which are differentiated from
granulosa cells. These cumulous cells are mucous-like and will protect the oocyte and
help carry it down the oviduct, fallopian tube in humans. The leftover follicular cells will
develop into the corpus luteum, which will produce progesterone6,16,17. If the oocyte does
not get fertilized and no pregnancy occurs, then the corpus luteum will degrade, stop
synthesizing progesterone, and the uterine lining will degrade and return to normal15. If
pregnancy does occur, the corpus luteum is responsible for continued progesterone
production, which keeps the uterine wall thick and full of blood vessels for zygote
development16.
The ovarian tissue, specifically the theca and granulosa cells, are believed to be
derived from the immune system. Both cell types, especially theca cells, are capable of
secreting interleukin-8, which is a major recruitment factor for leukocytes10. Monocytes
are able to induce this secretion in ovarian tissue10. Corpus luteum formation and
9

degradation, like ovulation, is also highly associated with immune cell changes16.
Granulosa-lutein cells have been implicated as a source of chemokine release, which is
necessary for attracting leukocytes to help with corpus luteum remodeling2. One study
was able to show an increase in interleukin-8 production in cultures of granulosa lutein
cells and leukocytes compared to cultures of only granulosa lutein cells1,2. The
interaction between ovarian cells and leukocytes seems to be effective at optimizing
production of chemokines and hormones1. The regulation of chemokine production in
ovarian cells is thought to involve stimuli such as hCG, tumor necrosis factor-alpha, and
interleukin-12. The changes in chemokine expression are also cyclic, indicating
leukocyte infiltration is necessary at precise times in the estrus cycle1. Neutrophils are an
important inflammatory cell that have been found in ovarian tissue during ovulation,
specifically around the thecal layer of follicles2. Neutrophils are abundant during corpus
luteal formation, while monocytes and macrophages seem to dominate during corpus
luteal degradation1,16.
Reproductive Diseases
Polycystic ovary syndrome (PCOS) is the most common reproductive endocrine
disorder among women, affecting an estimated one in five women of reproductive age in
the United States18,19. The disease often presents with enlarged ovaries that have cysts on
them, limiting function and estrogen production, ultimately resulting in hormonal
imbalance. The hormonal imbalance causes the manifestation of symptoms such as
excessive acne, balding or hair thinning, amenorrhea or irregular menstruation, facial hair
growth, insulin resistance and obesity20. PCOS can also lead to hypertension, diabetes,
and a metabolic syndrome19. This disease is often associated with reproductive
10

challenges and infertility. One chemokine, monocyte chemoattractant protein-1, has been
identified in follicular fluid and serum in women with PCOS in increased levels
compared to healthy women19. Increased serum levels of this particular chemokine may
be promoting the insulin resistance and obesity that is seen in PCOS women19. This
suggests that specific amounts of chemokines, cytokines and leukocytes are required in
the reproductive tissue of healthy women ONLY at precise times, with quantities outside
that threshold resulting in reproductive irregularities and diseases.
Endometriosis is another major reproductive disorder, characterized by the
abnormal ectopic growth of endometrial tissue outside the uterine cavity21,22. This
disease has been associated with decreased function of T cells and natural killer cells, and
increased activation and infiltration of macrophages21,22.
Spleen
The spleen is a secondary lymphoid organ which functions to filter blood,
removing old red blood cells and monitoring for and removing abnormal or pathogenic
particles via its resident population of immune cells23,24. Monocytes and macrophages,
among other leukocytes, can be found in the spleen24. The spleen has recently been
identified as a reservoir for leukocytes, acting as an immediate source of white blood
cells when tissue becomes damaged or inflamed23. This is in contrast to the bone
marrow, which is a much slower acting source of leukocytes for damaged tissue. In
particular, ly6𝑐 ℎ𝑖𝑔ℎ and ly6𝑐 𝑙𝑜𝑤 monocytes have been found in the red pulp of the spleen,
and the ly6𝑐 ℎ𝑖𝑔ℎ monocytes in particular have been proven to be specifically recruited
from the spleen to sites of tissue injury23. One study found that, after inducing ischemia
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of the myocardium, there was a decrease in ly6c monocyte numbers in the spleen, an
increase in their numbers in the blood, and no change in bone marrow numbers,
indicating the monocytes left the spleen and entered circulation to reach the site of
injury23. However, this same study showed that neutrophil numbers in the spleen did not
change23.
The immune system plays an important role in the reproductive system, as an
abnormal immune system is associated with various fertility complications, such as
preeclampsia, intrauterine growth restriction, and recurring abortions24. There has been
some indication that the spleen is the source of leukocyte donation for the ovary, as
splenectomized mice have reduced ovulation rates compared to both mice with intact
spleens or mice that have been reconstituted with splenocytes8. Furthermore, women
who have had splenectomies and become pregnant endured more hardships than women
who had a spleen, including the increased need for caesarian section and fertility
treatment, and a higher risk for preterm delivery24. It has also been demonstrated that an
inverse correlation between leukocyte numbers in the spleen and in the ovary exists
during ovulation7. This suggests that the spleen may play a role in the reproductive
system, and may also act as a source of leukocytes for normal, physiological
inflammatory processes, such as ovulation. The spleen is likely supplying leukocytes to
reproductive tissues, such as the ovary, oviduct, and uterus, to facilitate a rapid and
timely ovulation. Furthermore, bone marrow transplants have been shown to be effective
at restoring ovulation rates in rodents with defective white blood cells3. Sources of white
blood cells, like the spleen or bone marrow, may both be capable of restoring ovulatory
function.
12

Figure 3. Splenic leukocyte recruitment to ovary.
The spleen may act as a reservoir for leukocytes, releasing them in response to chemokines
released by ovarian cells. Following ovarian infiltration, the leukocytes migrate to a mature
follicle, and begin to release cytokines and chemokines to help break down the follicle membrane
so that ovulation can occur. Source: Pituitary-ovary-spleen axis in ovulation. Oakley OR, Frazer
ML, and Ko C. (2011). Trends in endocrinology and metabolism: TEM 22, pp.345-352.

Ly6𝒄𝒉𝒊𝒈𝒉 Monocyte
Monocytes are innate white blood cells that arise in the bone marrow and travel
through the vasculature to inflamed or infected tissue sites, where they eventually
differentiate into macrophages or dendritic cells25-29. They are typically some of the first
leukocytes to arrive at inflammatory sites4,28. Peripheral inflammation is typically a
primary signal causing increased production of monocytes27. In the vasculature,
monocytes interact with cell adhesion molecules, such as the vascular cell adhesion
molecule (VCAM-1) and the intercellular adhesion molecule (ICAM-1), expressed by the
endothelium which help slow the monocytes so that they can pass through the
endothelium to reach the inflamed tissue and differentiate into macrophages30.
13

Monocytes are characterized by the expression of CD11b, CD115 in mice, CD14 and
CD16 in humans, and lack the surface markers expressed by B, T, natural killer, and
dendritic cells, which include B220, CD3, NK1.1, MHCII (IA), and CD90.225,27. They
are also distinguishable from their differentiated forms, macrophage and dendritic cells,
by their lack of F4/80 glycoprotein and CD11c expression23. There are two predominant
subsets of monocytes, which are the ly6𝑐 ℎ𝑖𝑔ℎ and ly6𝑐 𝑙𝑜𝑤 monocyte, named by the
variable levels of expression of ly6c (lymphocyte antigen 6c)23. These two subsets are
functionally distinct and express different surface markers23,28. The ly6𝑐 ℎ𝑖𝑔ℎ monocyte is
inflammatory while ly6𝑐 𝑙𝑜𝑤 monocyte is involved in the resolution of
inflammation23,25,28,31.

Figure 4. Two functionally distinct subsets of monocytes.
14

The ly6𝒄𝒉𝒊𝒈𝒉 monocyte can differentiate into an inflammatory M1-like macrophage upon tissue
infiltration. It can also patrol the vasculature, decreasing ly6c expression to become a ly6𝒄𝒍𝒐𝒘
monocyte. The ly6𝒄𝒍𝒐𝒘 monocyte can differentiate into an M1-like macrophage upon tissue
infiltration, which functions primarily to resolve inflammation and repair tissue.32 Source:
Monocytes in atherosclerosis: subsets and functions. Woollard, K. J. & Geissmann, F. Nature
reviews. Cardiology 7, 77-86, doi:10.1038/nrcardio.2009.228 (2010).

The ly6𝑐 ℎ𝑖𝑔ℎ monocytes are short-lived cells involved in inflammatory processes
and typically migrate to infected or inflamed tissue25,27,28,31,33. Ly6𝑐 ℎ𝑖𝑔ℎ populations are
a transitory subset because they quickly begin to lower expression of ly6c after entering
the circulation and tissues27,28. These inflammatory monocytes are typically one of the
first immune cells to arrive at a site of injury34. They are larger than their ly6𝑐 𝑙𝑜𝑤
counterpart23 and express the chemokine receptor 𝐶𝑋3CR1 in low levels, but express high
levels of Ly6c (Gr-1) and the chemokine CCR225,26,28,31,33. In humans, this same
monocyte is classified as 𝐶𝑋3CR1𝑙𝑜𝑤 𝐶𝐷14ℎ𝑖𝑔ℎ for surface receptor expression31. CCR2
is the major chemokine receptor utilized by this monocyte to infiltrate inflamed tissues
and cross the endothelium26,31,35. Blocking CCR2 activity results in drastically reduced
monocyte numbers31. Similarly, knocking out the gene for CCR2 (CCR2−/− ) in mice
also causes drastically decreased recruitment of monocytes and macrophages to tissue36.
Ly6𝑐 ℎ𝑖𝑔ℎ monocytes also express chemokine receptors CCR7 and CCR8, and migrate
towards chemokines such as CCL2, CCL7, and CCL831. These chemokines were
previously named to reflect their function as monocyte chemoattractant proteins; for
instance, CCL2 was previously referred to as monocyte chemoattractant protein-1 (MCP1)5. These ligands are produced by endothelial tissue, helping recruit leukocytes to
specific tissues; in the pre-ovulatory ovary, CCL2 is produced by stroma cells near the
follicle, recruiting macrophages to this specific site1. They are also produced by
fibroblasts, smooth muscle cells, and other monocytes, macrophages, and
15

lymphocytes19,29. CCL2 production is often increased in response to inflammatory
stimuli such as TNF-α, interferon-gamma (IFN-γ), and lipopolysaccharide, which is a
product of pathogens29. In addition, it escalates an inflammatory process by stimulating
adhesion molecule and cytokine production35. Another molecule present on the ly6𝑐 ℎ𝑖𝑔ℎ
monocyte is L-selectin, or CD62L, that facilitates the monocyte homing to inflamed
tissues27. This subset of monocytes can differentiate into ly6𝑐 𝑙𝑜𝑤 monocytes simply by
decreasing expression of ly6c or develop into an M1 macrophage, the classical proinflammatory macrophage26,27,30,33. Since it can differentiate into a ly6𝑐 𝑙𝑜𝑤 monocyte, it
can further differentiate into wound repair M2 type macrophages34. Though most
monocytes differentiate into macrophages upon exiting the bloodstream, this transition is
not always immediate34. These monocytes can also exhibit regulatory functions on other
white blood cells, such as neutrophils, and stop them from becoming activated by
producing prostaglandin E2 (PG𝐸2 ) and interleukin-1037. One study was able to show
that in the presence of commensal bacteria, ly6𝑐 ℎ𝑖𝑔ℎ were able to take on a regulatory
role in addition to their inflammatory role, to limit collateral damage from other
inflammatory leukocytes, especially neutrophils37.
In the ovary, these monocytes would be found before ovulation occurs, as they
promote the inflammation and swelling of the ovarian follicles. The follicles will
eventually rupture and release oocytes for fertilization. They may also be involved in the
process of corpus luteum degradation, which would be highly inflammatory. Monocytes
may also be playing a regulatory role on the ovarian cells, causing granulosa-lutein cells
to secrete interleukin-8 and MCP-1, which would prompt the recruitment of more
leukocytes6,10. Furthermore, they may be able to regulate other inflammatory cells, like
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neutrophils, and prevent them from releasing damaging products too early or in too high
a concentration37.
Ly6𝒄𝒍𝒐𝒘 Monocyte
The ly6𝑐 𝑙𝑜𝑤 monocytes are non-inflammatory; they promote wound healing,
tissue repair and remodeling23,33. These monocytes are also capable of promoting
angiogenesis and fibrosis in wounds34. The ly6𝑐 𝑙𝑜𝑤 monocytes are also better at
processing apoptotic cells than their counterpart, which helps them in repairing tissue33.
These monocytes express the chemokine receptor 𝐶𝑋3CR1 in high levels, but express
low levels of ly6c and the chemokine CCR225-27,31,33. This monocyte in humans can be
characterized as having 𝐶𝑋3CR1ℎ𝑖𝑔ℎ 𝐶𝐷14𝑙𝑜𝑤 𝐶𝐷16ℎ𝑖𝑔ℎ expression31. The ly6𝑐 𝑙𝑜𝑤
monocytes are recruited to tissues where there is an excess of 𝐶𝑋3CL1, also known as
fractalkine, that is expressed on endothelial tissue and smooth muscle cells5,25-27,35,38.
Fractalkine is able to cause monocyte adhesion and facilitate chemotaxis25,38. Fractalkine
is also specialized in that it is able to be cleaved from its membrane-bound form into a
soluble product that can accumulate to further promote chemotaxis of monocytes35,38,39.
This particular chemokine binds to the G-coupled protein receptor 𝐶𝑋3CR1, which is
expressed by monocytes and macrophages38. Fractalkine increases when responding to
hCG, resulting in increased production of progesterone by granulosa cells1. These
monocytes are longer-lived cells and can become residential macrophages in tissues,
especially those that are noninflamed25-27,31,33. This subset of monocytes has been
described as an intermediate between ly6𝑐 ℎ𝑖𝑔ℎ monocytes and ly6𝑐 𝑙𝑜𝑤 macrophages, as
ly6𝑐 ℎ𝑖𝑔ℎ monocytes gradually reduce ly6c expression27,31,34. They can also differentiate
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into the alternatively activated M2 macrophage, that promotes tissue repair and
remodeling30.
In the ovary, these monocytes would appear after ovulation has occurred,
indicating they could repair the ruptured follicle tissue. This monocyte may also be
involved in corpus luteal formation, which is needed upon successful fertilization of an
oocyte1. Corpus luteal formation involves a tremendous amount of tissue remodeling and
vascularization, suggesting these monocytes may play a role in the task.
M1 Macrophage
Monocytes that enter tissue will eventually differentiate into macrophages,
especially if they come into contact with M-CSF27. Macrophages are cells that are
involved in the innate immune system, and can help destroy pathogens, remove apoptotic
cells, and promote angiogenesis40. Monocyte differentiation is dependent on the tissue
environment they enter and whether they encounter inflammatory or anti-inflammatory
cytokines, chemokines, or other products. Monocytes can be either classically or
alternatively activated, causing them to turn into either a more damaging M1 macrophage
or a wound-healing M2 macrophage, respectively. Macrophages have been implicated in
playing a role in ovulation, with a variety of studies finding the presence of macrophages
in ovarian tissue during ovulatory events3. Macrophages have also been identified as the
most abundant type of leukocyte in the ovary40. Macrophages can promote angiogenesis
and are involved in maintaining the vasculature of the corpus luteum40.
M1-like macrophages appear after monocytes encounter lipopolysaccharide,
interferon-gamma (IFN-γ), and tumor necrosis factor alpha (TNF-α), which are all
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inflammatory signals30,40. The M1 macrophages will continue to promote inflammatory
processes and proteolysis of tissue by secreting such cytokines as IL-6 and IL-12, as well
as TNF-α and IFN- γ 30,34,40. They will also release CCL2, CCL7, and CCL8, which will
recruit more ly6𝑐 ℎ𝑖𝑔ℎ monocytes to the inflamed tissue30. M1-macrophages are powerful
effector cells; they destroy pathogens and apoptotic cells, as well as promote the
progression of the inflammatory process40. M1-like macrophages have been identified in
the regressing corpus luteum, likely cleaning up dead or dying cells1,40. Inflammatory
products, such as TNF-α, also increase during luteolysis, helping to promote apoptosis of
luteal cells while recruiting more leukocytes1.
M2 Macrophage
The ly6𝑐 𝑙𝑜𝑤 monocytes develop into the alternatively activated M2-like
macrophages, that are responsible for cleaning up and repairing damaged tissue, as well
as remodeling it. These macrophages are often called wound healing macrophages. M2like macrophages are more likely to appear in environments filled with anti-inflammatory
products, such as interleukin-4 (IL-4), interleukin-10 (IL-10), and interleukin-13 (IL13)40. They can produce a variety of anti-inflammatory mediators, such as tumor growth
factor-beta (TGF-β)34 and vascular endothelial growth factor (VEGF), that promotes
angiogenesis40. These macrophages are characterized by low expression of ly6c and high
expression of F4/80 and MHC class II, as well as the expression of CD206 (mannose
receptor), Mer tyrosine kinase (MerTK), and FC receptors CD23 and CD6434. M2-like
macrophages are also anti-inflammatory and can induce apoptosis in other immune cells,
such as neutrophils, to reduce overall inflammatory reactions 34. They stimulate CD4+ T
helper 2 cells and regulatory cells, which along with the M2 macrophage, are better able
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to regulate immune processes and help tissue repair40. M2-like macrophages have been
found in the developing corpus luteum in high levels, suggestive of an involvement in
promoting angiogenesis40. These cells may also help regulate immune responses in the
ovary during these complex processes in a homeostatic manner1.
Neutrophils
Neutrophils are polymorphonuclear granulocytes and are the most abundant of
circulating leukocytes40. They are short lived cells that are part of the innate immune
system, responding early to inflammatory stimuli40. Granulocyte colony stimulating
factor promotes the proliferation of neutrophils40. Neutrophils produce very toxic and
damaging products, such as reactive oxygen species (ROS), proteases, superoxides, and
cytokines, that both clear pathogens and destroy tissue17,37. They also contain many
proteolytic enzymes, such as collagenases and elastases, that are used to degrade
extracellular matrix to facilitate extravasation into tissues5,17. These granulocytic
leukocytes are both attracted to and activated by Interleukin-84,5. Another potent factor
causing neutrophil attraction is growth-regulated oncogene-α4,5. Both of these
chemoattractants can be categorized into the CXC subfamily of chemokines4,5.
Neutrophils have been shown to appear in ovarian follicles before ovulation takes
place, suggesting they play a role in the inflammatory process leading to ovulation3,4,6.
Specifically, they have been found accumulate in the theca layers of preovulatory
ovaries3,4. They have also been found around follicles that rupture abnormally3. In
support of this idea, administering neutralizing antibodies against neutrophils reduces
ovulation rates in rats3,40. A similar effect occurs when antibodies are given against IL-8,
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which inhibits neutrophils from entering tissue, resulting in decreased ovulation rate3.
Neutrophils may be modulated in the ovulation process by ly6𝑐 ℎ𝑖𝑔ℎ monocytes that
produce PG𝐸2 37. PG𝐸2 is able to regulate smooth muscle cells, endothelial cells and
white blood cells and their production of cytokines, chemokines, and expression of
adhesion molecules41. This regulation of activity might help to keep the neutrophils from
weakening follicular walls until optimal conditions are met and oocytes are ready to burst
from the follicle. Neutrophils may also play a role after ovulation in corpus luteum
development by promoting angiogenesis1,40.
Chemotaxis
Chemotaxis is the movement of a cell from one area to another in response to a
specific chemical gradient or cue, and is typically a major process involved in immune
responses6,42. This process can both attract and repel specific cells, based on the cue
provided6. Leukocytes are constantly monitoring the body for immune disturbances by
circulating through the blood stream until they are attracted to a particular site in response
to chemokines, which are soluble proteins that promote chemotaxis6. In many instances,
chemokines, which are small, low molecular weight cytokines with chemoattractant
properties, are responsible for chemotaxis, as well as leukocyte activation5,10,36,43.
Chemokines are structurally very similar and are divided into four subfamilies based on
the location of their cysteine residues, which are C, CC, CXC, and C𝑋3C4,5,10,21,42,43.
Because of their comparable structures, many chemokines share similar functions,
making them redundant. Chemokines are typically inflammatory as they can activate
leukocytes and effectively recruit leukocytes to sub-endothelial tissues42,44. Chemokines
are produced and released by endothelial cells and stromal cells, that assist leukocytes in
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determining where they need to go, and also by leukocytes themselves, self-promoting
the number of leukocytes recruited6. Some important leukocytes recruited to tissue via
chemokine gradients include monocytes, macrophages and neutrophils, which are often
the first immune cells to appear at inflammatory sites. Chemokines in the CC family tend
to recruit monocytes and lymphocytes, while neutrophils respond primarily to the CXC
subfamily5,21. Several chemokines have been found in and around follicles in the ovary
and have thus been implicated in ovarian function5. Chemokine regulation in the ovary is
complex and specific, allowing for specific leukocytes to be recruited to precise locations
in the ovary at optimal times to cause ovulation and the following reproductive processes
to occur efficiently5.
Monocyte chemoattractant proteins 1, 2, and 3 (MCP-1, MCP-2, MCP-3), also
called CCL2, CCL8, and CCL7, respectively, are some of the primary chemokines
responsible for the chemotaxis of monocytes36,42,45,46. These chemokines are categorized
into the CC subfamily (or beta family) and have approximately 70% shared homologous
structure36,42,44,45. CCL2 can be produced by a variety of cells, including endometrial
stromal cells and mesothelial cells, in response to a variety of triggers, such as estrogen21.
CCL2 is involved in follicle development, ovulation, steroidogenesis, and corpus luteum
formation, which suggests that hormones may be acting as catalysts to increase
production of CCL219. They also are produced in response to inflammatory signals, such
as cytokines29. The monocyte chemoattractant proteins bind to G-protein coupled
receptors (GPCRs), resulting in various signaling cascades5,36,42,45,46. The chemokine
receptor CCR2 is an example of one of these GPCRs on monocytes, which is expressed
in abundance and is the predominant receptor allowing for monocyte recruitment, only
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binding specifically to monocyte chemoattractant proteins29,36,42,44,46,47. There are two
isoforms of CCR2, named alpha and beta, in humans, but only one form in mice36.
Knockout of the CCR2 gene results in greatly decreased monocyte and macrophage
recruitment to tissue, showing just how important this receptor is for monocyte
recruitment36. CCL2 has been identified in the pre-ovulatory ovary, as well as indicated
as a likely player in corpus luteum formation, as it has angiogenic abilities5. It is also one
of the major chemokines involved in corpus luteum degradation, and is considered an
indicator of luteolysis5. The presence of CCL2 in such high levels in the ovary at each of
these reproductive stages suggests the necessity of monocyte involvement.
Neutrophils and other leukocytes are both drawn toward and activated by the
chemokine interleukin-8 (IL-8)2,4-6,45. Interleukin-8 is classified as a CXC (alpha family)
chemokine2,4-6,10. This chemokine has been found in both human follicular fluid and
granulosa-lutein cells in pre-ovulatory follicles, indicating the presence of neutrophils
during ovulation1,10. Furthermore, IL-8 is secreted by theca cells and granulosa cells, as
well as leukocytes, indicating there is a necessity for white blood cells in the ovary2,6,10.
The level of IL-8 secreted increases as follicles grow, with the highest amounts produced
by dominant follicles10. IL-8 may also be a regulator of steroid synthesis in the ovary and
initiate ovulatory events10. Another likely chemoattractant for neutrophils are the
collagen-like peptides that result from tissue degradation of the basement membrane in
ovarian follicles3,17. Growth regulated oncogenes (GRO) are also members of the CXC
family; they are primarily chemotactic for neutrophils but can also be potent activators of
them as well3-5,45. They bind to the CXCR2 receptor, while IL-8 can bind to both the
CXCR1 and CXCR2 receptors45. Growth related oncogenes are more chemotactically
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potent than interleukin-84. The expression of GRO has been found in the pre-ovulatory
ovary of rats3. Both IL-8 and GRO-α have been found in high concentrations in human
follicular fluid4. They have also been determined to be expressed on preovulatory
follicles5. TNF-α, which is an inflammatory product itself, has been identified as a signal
that causes increased production of both GRO-α and IL-8 in granulosa lutein cells4,5.
Estrogen, which can modulate many physiological processes, has been demonstrated as
being capable of reducing GRO3 (CXCL3), thereby reducing neutrophil recruitment11.
Another modulator of GRO expression is hCG, which is able to increase GRO
expression5. It may also be that different mechanisms of recruitment are enacted to draw
neutrophils to specific locations. In one study where indomethacin was used to inhibit
neutrophil infiltration into the ovary, it was shown that neutrophils were blocked from
entering the medulla but still were able to reach the follicle, suggesting multiple
mechanisms of recruitment3. GRO and IL-8 are capable of promoting angiogenesis, and
therefore have a possible role in corpus luteum development5,6. Furthermore, these two
chemokines have been found in the pre-ovulatory ovary, suggesting that neutrophils are a
major class of white blood cells stimulating reproductive processes such as ovulation5.
There are also adhesion molecules on endothelial tissue which alter in expression
to recruit immune cells through extravasation. Expression of adhesion molecules on
endothelial tissue are necessary for leukocyte recruitment; they work by slowing down
circulating leukocytes and helping them adhere to endothelial tissue, and then by drawing
them through the endothelium into tissues that require them. These molecules include
platelet-endothelial cell adhesion molecule -1 (PECAM-1, CD31), intercellular adhesion
molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1), and E-selectin, all of
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which play a role in stimulating leukocyte recruitment from circulation into tissue.
PECAM-1, through intracellular signaling, can induce activation in other inflammatory
genes, like ICAM-1, to promote the inflammatory process7. ICAM-1 is able to help
leukocytes slow down and adhere to endothelial tissue, so that PECAM-1 can be more
effective at drawing them into tissue from circulation7. Both PECAM-1 and ICAM-1
have increased expression prior to ovulation, indicating leukocytes are actively recruited
to the ovary7.
Fractalkine, or C𝑋3 𝐶𝐿1, is a chemokine that falls into the C𝑋3 𝐶 family; however
it is different from other chemokines because it is the only member in this class43.
Fractalkine is expressed on the membrane of endothelial cells and smooth muscle cells,
signaling leukocytes to adhere to specific tissue35,38. This adherence helps leukocytes
lose velocity in the bloodstream and stick to vessel walls, facilitating migration into the
tissues. Fractalkine expression varies depending on the environment; inflammatory
stimuli such as LPS decrease expression, while factors such as IL-10, have the alternative
effect of increasing expression38. Furthermore, fractalkine is unique compared to other
chemokines as it can also be cleaved by TNF-α-converting enzyme, which leaves behind
soluble fractalkine39,43. This soluble form can aggregate in large quantities and act as a
chemoattractant for leukocytes as well as smooth muscle cells43. Any cell expressing
C𝑋3 𝐶𝑅1, the receptor for C𝑋3 𝐶𝐿1, is capable of adhering to or migrating towards this
ligand38. In addition to these functions, fractalkine can also induce proliferation of
smooth muscle cells by acting on epidermal growth factor receptor39,43. Epiregulin, the
ligand for epidermal growth factor receptor, seems to be regulated by the fractalkine
ligand, causing increased production of it, which causes cell proliferation43. Fractalkine,
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along with CCL2 and IL-8, are some of the few chemokines that are capable of inducing
smooth muscle cell proliferation43. Furthermore, epiregulin can be induced by
angiogenic factors such as angiotensin II and thrombin, suggesting that cells involved in
angiogenesis would be drawn towards epiregulin, as well as fractalkine43. In the ovary,
each of these factors may play a role in corpus luteum formation that involves the rapid
revascularization of tissue.
Hormone fluctuations in the ovary may be playing a key role in regulating
expression of many of these chemokines in ovarian cells, as chemokine expression seems
to be cyclic1,19. Luteinizing hormone may be one of the most influential hormones in
altering chemokine expression in a timely fashion3. CCL2 levels have been correlated to
LH levels19. Estrogen may also be involved in regulating time dependent expression of
various cytokines and chemokines7. For example, following lowered levels of estradiol,
macrophage numbers increase for luteal regression1.
The reproductive system is complex; many cellular signals are required to recruit
the cells that play pivotal roles in coordinating ovulation and corpus luteum formation.
These signals, which include both hormones and chemokines, are precisely regulated to
recruit white blood cells, such as monocytes and macrophages. These white blood cells
then facilitate dynamic changes in ovarian tissue by promoting both inflammation and
tissue repair, making follicular growth, ovulation, and corpus luteum formation possible.
Gaining insight as to which cells and signals are involved in the reproductive system, as
well as the complex interaction between them, will ultimately lead to a better
understanding of fertility and fertility abnormalities.
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Chapter 2
Material & Methods
Animal Handling and Hormone Injections
Female cd1 and balb/c mice were obtained from Charles River (Roanoke, IL) at
approximately three weeks of age and allowed to acclimate for one week. Mice were
then stimulated to ovulate via intraperitoneal injection using a super ovulation protocol
(SP). This included using 10 IU of pregnant mare serum gonadotropin (PMSG)(G4877;
Sigma, St. Louis, MO) followed 48 hrs later by 10 IU of human chorionic gonadotropin
(hCG)(CG10; Sigma). Mice were euthanatized via carbon dioxide asphyxiation followed
by cervical dislocation at the following time points post hormone injection: 48 hr post
PMSG, 6 hr post hCG, 12 hr post hCG, 20 hr post hCG, and 24 hr post hCG. All animal
procedures were approved by Eastern Kentucky University’s Animal Care and Use
Committee.
Tissue Isolation and Flow Cytometry
Spleens and ovaries were collected from all mice and processed accordingly. Cell
counts were performed by running 40μl of a 1:50 dilution of spleen and 1:10 dilution of
ovarian cells on the Accuri C6 flow cytometer. Single cell suspensions of approximately
1x106 cells were then stained with antibodies specific to monocytes using a panel
described in Table 1 and with antibodies specific to macrophages and other white blood
cells using a panel described in Table 2. Other panels were used to find M2-like
macrophages (Table 3) and generalized white blood cells (Table 4). Cells were washed
once with PBA and then with PBS. Cells were resuspended in 50ul PBS and analyzed
using an Accuri C6 flow cytometer (BD Biosciences, San Jose, CA). Monocytes and
macrophages were determined as a lineage− (all PE conjugated antibodies) and
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CD11b+ population (Fig. 1). Ly-6c high monocytes were determined as the f4/
80− CD11c − Ia− and Ly − 6c + population (Fig. 1). Ly-6c low monocytes were
determined as the f4/80− CD11c − Ia− and Ly − 6c − population (Fig. 1). Macrophages
were determined as the f4/80+ CD11c + Ia+ and Ly − 6c − population (Fig. 1). Data was
compensated on the BD Accuri software. Data were analyzed and plotted using
SigmaPlot version 11.0 (Systat Software, Inc., Chicago, IL). On graphs, error bars
represent one SEM around the average of data per group. One-way ANOVA (Tukey
test) was used to determine statistical significance among groups. P < 0.05 was
considered significant.
Table 1. Antibodies and concentration used when creating cell staining mixture for finding
macrophages, Ly6𝒄𝒉𝒊𝒈𝒉 and Ly6𝒄𝒍𝒐𝒘 monocytes.

Fluorochrome

Antibody Company

Cat.

Dilution

No.

Amount
(ul)

PBA

-

-

-

-

680

FITC

Ly-6c

BD

553104

1:20

34

557657

1:20

34

553005

1:20

34

553090

1:20

34

Biosciences
APC-Cy7

CD11b

BD
Biosciences

PE

CD90.2

BD
Biosciences

PE

B220

BD
Biosciences
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Table 1 (continued).

Fluorochrome

Antibody Company

Cat.

Dilution

No.
PE

CD49b

BD

Amount
(ul)

558759

1:20

34

557391

1:20

34

561104

1:20

34

Biosciences
PE

NK1.1

BD
Biosciences

PE

LY-6g

BD
Biosciences

APC

f4/80

Biolegend

13116

1:20

34

APC

CD11c

BD

561119

1:20

34

562823

1:20

34

Biosciences
APC

Ia

BD
Biosciences

Notes: All antibodies are mixed into PBA. 20ul of the mixture was added to each cell suspension
and allowed to stain for a minimum of 20 minutes at 4°C. Amounts listed account for staining 30
samples. Monocyte panel was designed based off of a previous study23. The Accuri C6 was set
to collect 50,000 events. Laser settings were set to two red and two blue lasers. FL1 lens was
533/30, FL 2 lens was 585/40, FL 3 lens was 780/60, and FL4 lens was 675/25.
Table 2. M1-like macrophage panel.

Fluorochrome

Antibody Company

Cat.

Dilution

No.

Amount
(ul)

PBA

-

-

-

-

680

Alexa488

CD197

Biolegend

120110

1:20

34

PE

F4/80

Biolegend

123110

1:20

34
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Table 2 (continued).

Fluorochrome

Antibody Company

Cat.

Dilution

No.
APC-Cy7

CD3

BD

Amount
(ul)

560590

1:20

34

562367

1:20

34

Biosciences
Alexa647

Ia

BD
Biosciences

Notes: Antibodies and concentration used when creating cell staining mixture for M1
macrophages. All antibodies were mixed into PBA. 20ul of the mixture was added to each cell
suspension to stain for 20 minutes at 4°C. Amounts account for the staining of 30 samples. The
Accuri C6 was set to collect 50,000 events. Laser settings were set to three red and one blue
lasers. FL1 lens was 533/30, FL 2 lens was 585/40, FL 3 lens was 670LP, and FL4 lens was
675/25.

Figure 5. Identification of monocyte and macrophage populations out of all leukocyte
populations.
The graph on the left identifies all monocytes and macrophages as lineage negative and cd11b
positive cells. The graph on the right specifically identifies ly-6c high and ly-6c low monocyte
subsets and macrophages as positive for F4/80, cd11c, and IA within the first population
identified (cd11b positive, lineage negative cells).
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Additional Antibody Panels
Table 3. M2-like macrophage panel.

Fluorochrome

Antibody Company

Cat.

Dilution

No.

Amount
(ul)

PBA

-

-

-

-

680

FITC

CD23

BD

553138

1:20

34

Biosciences
PE

F4/80

Biolegend

123110

1:20

34

PE-Cy7

CD206

BD

141720

1:20

34

550261

1:20

34

553142

-

10

Biosciences
APC

CD11c

BD
Biosciences

-

FC Block

BD
Biosciences

Notes: Antibodies and concentration used when creating cell staining mixture for M2-like
macrophages. All antibodies were mixed into PBA. FC Block was added to cell suspensions for
20 minutes before the antibody mixture was added. 20ul of the mixture was added to each cell
suspension to stain for 20 minutes at 4°C. Amounts account for the staining of 30 samples. The
Accuri C6 was set to collect 50,000 events. Laser settings were set to three red and one blue
lasers. FL1 lens was 533/30, FL 2 lens was 585/40, FL 3 lens was 670LP, and FL4 lens was
675/25.
Table 4. General white blood cell panel.

Fluorochrome

Antibody Company

Cat.

Dilution

No.
PBA

-

-

-

31

Amount
(ul)

-

680

Table 4 (continued).

Fluorochrome

Antibody Company

Cat.

Dilution

No.

Amount
(ul)

FITC

CD3

Ancell

703-040

1:20

34

PE

F4/80

Biolegend

123110

1:20

34

PercpCy5.5

Ly6g

BD

560602 1:20

34

1:20

34

Biosciences
APC

CD11c

BD

550261

Biosciences
Notes: Antibodies and concentration used when creating cell staining mixture for general white
blood cell populations. All antibodies were mixed into PBA. 20ul of the mixture was added to
each cell suspension to stain for 20 minutes at 4°C. Amounts account for the staining of 30
samples. The Accuri C6 was set to collect 50,000 events. Laser settings were set to three red and
one blue lasers. FL1 lens was 533/30, FL 2 lens was 585/40, FL 3 lens was 670LP, and FL4 lens
was 675/25.

Spleen Processing
Following euthanasia at the specified times, spleens were harvested and processed
by pushing them through 70µm filters and washed with PBS by centrifugation at 300xg
for five minutes at 4ºC. To reduce erythrocyte numbers, 3ml of 1x ACK was added for
one minute, after which 5ml of PBS was added to reduce ACK activity. Cells were then
washed twice with PBS by centrifugation. Cells were resuspended in 2ml of PBS and
cell counts were performed on the single cell suspensions at a 1:50 dilution on the BD
ACCURI. Protocol was borrowed from and utilized as previously described48.
Ovary Processing
Following euthanasia of mice at the specified times, both ovaries were harvested
and fatty tissue was carefully removed. Ovaries were then minced into approximately 20
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pieces and placed into 15ml tubes. To remove remaining fatty tissue pieces, 10ml PBS
was added to the tube, and all but 2ml of solution was removed from tube and disposed.
Ovarian cells were allowed to settle 30 minutes before collagenase DNase solution (CDS)
was added to break down collagen. Tubes containing CDS and ovary cells were then
incubated for 30 minutes at 37ºC. Mixtures were then dissolved further by using a
syringe with an 18G needle and filtered through a 70µm filter into a new 15ml tube.
Cells were then centrifuged at 300xg for five minutes at 4ºC, supernatant was dumped,
and cells were resuspended in 2ml HBSS. Cell counts were performed on the single cell
suspensions at a 1:10 dilution on the BD ACCURI. Protocol was borrowed from and
utilized as previously described7.
Cumulous Oocyte Complex Counts
Oviducts were collected from 20 hr post hCG mice in order to count cumulous
oocyte complexes (COCs). The oviducts were isolated and a small cut was made in the
ampulla to allow the COCs to exit the oviduct. The COCs were then counted under a
microscope. The average number found in one set (n=3) of hCG 20hr mice was
determined to be the ovulation rate.

33

Figure 6. Oviduct from a mouse.
The oviduct, after being isolated from the ovary. The ampulla is distinct from the rest of the
oviduct and it usually translucent. Most cumulous-oocyte complexes reside in the ampulla.
Photo courtesy of Dr. Phil Bridges.

Tissue embedding
Ovaries and spleen were collected from mice and formalin fixed for three hours,
then transferred to PBS. Tissues were dehydrated through a series of hour-long graded
ethanol baths. They were then transferred into two baths of room temperature Histoclear
II for an hour each and one bath of 55°C Histoclear II for 45 minutes for clearing. The
tissues were then placed into melted (55°C) paraffin to prepare for embedding. Tissues
were then embedded onto cassettes using disposable molds and a paraffin dispenser and
were allowed to dry overnight. Tissues were cut 7μm thick using a microtome. Slides
were allowed to dry overnight at 38°C.
Immunohistochemistry
Slides were then put in three 5 minute baths of Histoclear II to deparaffin,
followed by a graded series of ethanol baths for 2 minutes each to rehydrate the tissue.
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Tissues underwent antigen retrieval (specific to each primary antibody), which included
warming antigen Retrievagen A (BD Biosciences, Cat. No. 550524) or B (BD
Biosciences, Cat. No. 550527) in a microwave for 5 minutes to approximately 192°F and
then heating the slides in the solution for up to 20 minutes (Table 5). Slides were allowed
to cool for about 5 minutes. Tissue was circled with a pap pen. Bloxall (Vector, Cat. No.
SP-6000) was placed on all tissues for ten minutes to block endogenous peroxidase
binding. Slides were rinsed with Tris Buffered Saline (TBS) with Tween and then 10%
Normal Goat Serum Block (Vector, Cat. No. S-1000) was applied to all tissue for 5
minutes. Normal serum was dumped off and primary antibody was applied (Table 5).
Primary antibody was rinsed off using TBS with Tween and then Goat anti-Rabbit
(Vector, Cat. No. BA-1000) at a 1:500 dilution was applied for 15 minutes. Slides were
again rinsed with TBS with Tween and then Elite ABC Reagent (Vector, Cat. No. PK7100) was added for 15 minutes. This solution was rinsed off using TBS with Tween and
then Cardassian DAB, (Biocare Medical, Cat. No. DBC859H), a chromagen substrate,
was added onto the tissue for 5 minutes or until color appeared. The chromagen substrate
was thoroughly rinsed off with TBS with Tween. Slides were then counterstained for 15
seconds with Hemotoxylin. Slides were then rinsed for two minutes with 95% ethanol,
two washes of 100% ethanol for two minutes each, and two washed of Histoclear II for
two minutes each. Slides were dried and a coverslip was placed over the tissue using
Permount. Slides were allowed to dry overnight and examined under microscope for
positive colored cells. Protocol borrowed from previous studies49.
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Table 5. Primary antibodies used in immunohistochemistry along with antigen retrieval
specifics and incubation times.

Primary

Company

Cat. No. Retrievagen

Dilution

Incubation

B220/

BD

557390

1:100

4°C,

CD45R

Biosciences

CD30

BD

Antibody
B, 5 min

overnight
553824

A, 10 min

1:100

Biosciences
Anti-PE-

R&D

CAM1

Systems

Anti-

Abcam

4°C,
overnight

af3628

A, 10 min

1:100

4°C,
overnight

ab68672

A, 20 min

1:2000

Room

neutrophil

temperature,

elastase

2 hours

antibody
CD45

Abcam

ab10558

A, 10 min

1:100

4°C,
overnight

Notes: Primary antibody dilutions are also included. B220 was used to identify B cells, CD30
was used to identify activated B and T cells, anti-PE-CAM was used to identify blood vessels and
endothelial cells, CD45 was used to identify white blood cells in general, and anti-elastase was
used to identify functional neutrophils.
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Chapter 3
Results
Leukocyte infiltration of ovary
Leukocyte infiltration into the ovary was counted by collecting total events by
flow cytometry. Cells were only counted if they were larger than red blood cells. A
significant increase was found in the group hCG 6hr compared to the control group,
showing the increase in leukocyte infiltration prior to ovulation.

Figure 7. Total cell count in ovaries during ovulation.
The number of leukocytes in the ovary increases during ovulation as compared to immature
control mice. The group hCG 6hr was significantly increased compared to the control. Different
letters show significant difference. Results represent mean ± SEM of n=3 mice and are
representative of 3 experiments (p<0.05, ANOVA + Tukey).

Ly6𝒄𝒉𝒊𝒈𝒉 Monocytes
Ly6𝑐 ℎ𝑖𝑔ℎ monocytes that were stained and counted by flow cytometry showed a
significant increase in percentages and absolute numbers for group hCG 6hr compared to
all other groups. For absolute numbers, hCG 12hr was also significantly increased
compared to the control group.
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Figure 8. Gating strategy for ly6c high and low monocytes.
An unstained sample of ovarian cells was used to create gates yielding positive populations
that were 1% or less which were then applied to all samples. Cell other than leukocytes were
gated out first based off of small size. CD11b+ and lineage negative cells were then selected and
narrowed into either ly6c high or low monocytes. These cells were further defined by lack of
expression of IA, F480, and CD11c. Ly6𝒄𝒉𝒊𝒈𝒉 monocytes fell into the lower right quadrant while
Ly6𝒄𝒍𝒐𝒘 monocytes fell into the lower left quadrant.
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Figure 9. Percentage (left) and absolute number (right) of ly6𝒄𝒉𝒊𝒈𝒉 monocytes in the ovary
at different time points during ovulation.
Demonstrates the influx of ly6𝒄𝒉𝒊𝒈𝒉 monocytes during ovulation, specifically before ovulation
occurs at hCG 6hr. Group hCG 6hr is significantly increased compared to all other groups in
both percentage and absolute numbers. Group hCG 12hr is also increased compared to control
for absolute numbers. Different letters show significant difference. Results represent mean ±
SEM of n=3 mice and are representative of 3 experiments (p<0.05, ANOVA + Tukey).

Ly6𝒄𝒍𝒐𝒘 Monocytes
The gating strategy for ly6𝑐 𝑙𝑜𝑤 monocytes was the same as depicted in figure 8.
Ly6𝑐 𝑙𝑜𝑤 monocytes showed a delayed increase in absolute numbers, appearing after
ovulation at the time point hCG 20hr. A significant increase was found in group hCG
20hr compared to groups control, PMSG 48hr, and hCG 12hr.
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Figure 10. Percentage (left) and absolute number (right) of ly6𝒄𝒍𝒐𝒘 monocytes in the ovary
during ovulation.
Demonstrate the appearance of ly6𝑐 𝑙𝑜𝑤 monocytes post ovulation. Group hCG 20hr is
significantly increased compared to groups control, PMSG 48hr, and hCG 12hr in absolute
numbers. Different letters show significant difference. Results represent mean ± SEM of n=3
mice and are representative of 3 experiments (p<0.05, ANOVA + Tukey).

CD11c+ Dendritic Cells
No significant difference was found for CD11c positive cells, nor was any trend
noticed. CD11c positive cells did not seem to be entering the ovary.
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Figure 11. Gating strategy for CD11c positive cells.
An unstained sample of ovarian cells was used to create gates yielding positive populations that
were 1% or less which were then applied to all samples. Cell other than leukocytes were gated
out first based off of small size. A histogram was then created showing all CD11c positive cells.
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Figure 12. Percentage (left) and absolute number (right) of CD11c+ staining cells in ovary
during ovulation.
Results do not show much of a trend, indicating static behavior for dendritic cells. No significant
difference between groups was found. Results represent mean ± SEM of n=3 mice and are
representative of 3 experiments (p<0.05, ANOVA + Tukey).
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CD206+ M2-like Macrophages
No significant difference was found for CD206 positive cells, nor was any trend
noticed. CD206 positive cells did not seem to be entering the ovary.

Figure 13. Gating strategy for CD206 positive cells.
An unstained sample of ovarian cells was used to create gates yielding positive populations that
were 1% or less which were then applied to all samples. Cell other than leukocytes were gated
out first based off of small size. Next F480+ cells were selected, and further defined on a
histogram as CD206 positive cells.
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Figure 14. Percentage (left) and absolute number (right) of CD206+ cells in ovary during
ovulation.
Results do not indicate any real trend. An increase in CD206 cells may be occurring at hCG 20hr
as absolute numbers doubled. No significant difference was found between groups. Results
represent mean ± SEM of n=3 mice and are representative of 3 experiments (p<0.05, ANOVA +
Tukey).

CD197+/IA+ M1-like Macrophages
No significant difference was found for CD197/Ia positive cells, nor was any trend
noticed. CD197/Ia positive cells did not seem to be entering the ovary.
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Figure 15. Gating strategy for M1-like macrophages.
An unstained sample of ovarian cells was used to create gates yielding positive populations that
were 1% or less which were then applied to all samples. Cell other than leukocytes were gated
out first based off of small size. Next F480+ cells were selected, and further defined as being
double positive for Ia and CD197. These cells fell into the upper right quadrant.
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Figure 16. Percentage (left) and absolute number (right) of CD197+/IA+ M1-like
Macrophages in the ovary during ovulation.
Results show an increase in M1-like macrophage absolute numbers during ovulation compared to
the control group. No significant difference was found between groups. Results represent mean
± SEM of n=3 mice and are representative of 3 experiments (p<0.05, ANOVA + Tukey).

Ly6g+ Neutrophils
No significant difference was found for Ly6g positive cells, although an
increasing trend was noticed in neutrophil numbers. Ly6g positive cells are likely
entering the ovary throughout ovulation.
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Figure 17. Gating strategy for ly6g+ cells.
An unstained sample of ovarian cells was used to create gates yielding positive populations that
were 1% or less which were then applied to all samples. Cell other than leukocytes were gated
out first based off of small size. A histogram was then created showing all ly6g positive cells.
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Figure 18. Percentage (left) and absolute number (right) of Ly6g+ neutrophils in the ovary
during ovulation.
Results indicate a trend showing an increase in neutrophil absolute numbers during ovulation
compared to the control group. No significant difference was found between groups. Results
represent mean ± SEM of n=3 mice and are representative of 3 experiments (p<0.05, ANOVA +
Tukey).

CD3+ T Cells
No significant difference was found for CD3 positive cells, nor was any trend
noticed. CD3 positive cells did not seem to be entering the ovary.
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Figure 19. Gating strategy for CD3+ cells.
An unstained sample of ovarian cells was used to create gates yielding positive populations that
were 1% or less which were then applied to all samples. Cell other than leukocytes were gated
out first based off of small size. A histogram was then created showing CD3 positive cells.
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Figure 20. Percentage (left) and absolute number (right) of CD3+ T cells in the ovary
during ovulation.
Results do not indicate any real trend. There was a significant difference between the control
group compared to all four other groups in percentage graph. Different letters show significant
difference. Results represent mean ± SEM of n=3 mice and are representative of 3 experiments
(p<0.05, ANOVA + Tukey).

F4/80+ Macrophages
No significant difference was found for F4/80 positive cells, although an
increasing trend was noticed in macrophage numbers. F4/80 positive cells are likely
appearing in the ovary during ovulation.
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Figure 21. Gating strategy for F480+ cells.
An unstained sample of ovarian cells was used to create gates yielding positive populations that
were 1% or less which were then applied to all samples. Cell other than leukocytes were gated
out first based off of small size. A histogram was then created displaying all F480 positive cells.
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Figure 22. Percentage (left) and absolute number (right) of F480+ T cells in the ovary
during ovulation.
Results suggest an increase in absolute numbers of macrophages during ovulation. No significant
difference was found between groups. Results represent mean ± SEM of n=3 mice and are
representative of 3 experiments (p<0.05, ANOVA + Tukey).

Recruitment of Leukocytes from Spleen
In percentage, a significant decrease, particularly for the 𝑙𝑦6𝑐ℎ𝑖𝑔ℎ monocyte, in
the spleen was demonstrated for groups hCG 6hr, hCG 12hr, and hCG 24hr compared to
the control. There was also a significant decrease in groups hCG 6hr compared to PMSG
48hr. For absolute number, a significant decrease in the spleen was demonstrated in
groups hCG 6hr and hCG 24hr compared to the control group. The spleen appears to be
losing 𝑙𝑦6𝑐ℎ𝑖𝑔ℎ monocytes during times that coincide with ovulation.
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Figure 23. Gating strategy for splenic leukocytes.
An unstained sample of ovarian cells was used to create gates yielding positive populations that
were 1% or less which were then applied to all samples. Cell other than leukocytes were gated
out first based off of small size. CD11b+ and lineage negative cells were then selected and
narrowed into either ly6c high or low monocytes. These cells were further defined by lack of
expression of IA, F480, and CD11c. Ly6𝑐 ℎ𝑖𝑔ℎ monocytes fell into the lower right quadrant while
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Ly6𝑐 𝑙𝑜𝑤 monocytes fell into the lower left quadrant.

Figure 24. Percentage (left) and absolute number (right) of ly6𝒄𝒉𝒊𝒈𝒉 monocytes in the spleen
at different time points during ovulation.
Demonstrates a trend that leukocyte numbers, particularly for ly6𝒄𝒉𝒊𝒈𝒉 monocytes, fall during
ovulation. Groups hCG 6hr, hCG 12hr, and hCG 24hr are significantly decreased compared to
the control group for percentage. Group hCG 6hr is also significantly lower compared to group
PMSG 48hr for percentage. For absolute numbers, groups hCG 6hr and hCG 24hr are
significantly lower than group PMSG 48hr. Different letters show significant difference. Results
represent mean ± SEM of n=3 mice and are representative of 3 experiments (p<0.05, ANOVA +
Tukey).

Cumulous Oocyte Complex Counts
Oviducts were first isolated from the ovaries in mice taken at hCG hour 20. The
ampulla of the oviduct was then cut, expelling most COCs from the oviduct in a clump.
Fine tweezers were then used to tease remaining COCs from the oviduct. The oocytes in
these complexes were then counted under microscope and then averaged to determine
ovulation rate. Ovulation rates ranged from 14 to 29. Reduced rates in trials 2, 4, and 5
had one mouse that did not have distinct ampullas full of COCs, which lowered the
overall ovulation rate.
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Figure 25. Ovulation rate determined by counting cumulous oocyte complexes in hCG 20hr
mice.
Oviducts were isolated in hCG 20hr mice and the ampulla was cut to release cumulous oocyte
complexes which were then counted. Numbers for both ovaries in mice were averaged to
determine ovulation rate. Average ovulation rate ranges between approximately 14 and 29.
Results represent mean of n=3 mice for seven experiments.

54

Figure 26. Cumulous oocyte complexes under the microscope.
Five distinct oocytes along with numerous small cumulous cells can be seen. Each visible oocyte
was counted and averaged per group to determine ovulation rates.
Immunohistochemistry
Ovary, oviduct, and spleen tissue were all stained with hematoxylin and eosin for basic cell
structures. A rat anti-mouse B220 primary antibody was utilized to detect B cells in all three
tissues. Cells stained positive for B220 in the spleen, but not in the ovary or oviduct, suggesting
B cells are not present or necessary in ovulation.
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Chapter 4
Discussion
Leukocyte infiltration into the ovaries is a key factor in the physiological process
of ovulation, that is now well recognized as an inflammatory response. We identified
several leukocyte populations infiltrating the ovarian tissue, including monocytes,
macrophages, and granulocytes including neutrophils and eosinophils. Previous studies
have identified a variety of leukocyte products found in the ovaries, including proteases,
cytokines, and chemokines, that promote leukocyte recruitment and inflammation. The
presence of leukocytes and their products indicates they are necessary for facilitating
ovarian processes, such as steroidogenesis, breakdown of the basement membrane of the
follicular wall for ovulation, angiogenesis and vascularization of the corpus luteum, and
degradation of a collapsing corpus luteum.
Referring to Figure 7, which shows the total number of cells in the ovary, it seems
clear that prior to ovulation, the cell totals begin to increase, and the ovary seems to
double in size. This was evident by observing ovaries taken from mice at each time point
during ovulation, as control mice had very small, pale ovaries, and mice at any stage
during ovulation had much bigger, pink ovaries. Upon close examination, many of these
ovaries also had multiple follicles visible. This indicates that leukocytes must serve some
function in the process of ovulation, although we believe they likely serve multiple
purposes. Many cells that come into the ovary prior to ovulation likely serve in an
inflammatory role, while the cells coming in after ovulation probably serve reparative
functions.
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The ly6𝑐 ℎ𝑖𝑔ℎ monocyte is one of the first cells we have identified that are
recruited the ovary prior to ovulation. These monocytes seem to peak in number at hCG
hour 6, which is before ovulation occurs in mice. This means they are most likely
involved in inflammatory processes, as they can differentiate into M1-like macrophages
and help to break down the wall of follicles in the ovary so that the oocyte can be
released. The numbers of these monocytes quickly decrease, as their role finishes when
ovulation occurs. This may indicate that they are either leaving the ovary or
differentiating into other cell types, including ly6𝑐 𝑙𝑜𝑤 monocytes, which can then
differentiate into M2-like macrophages for tissue repair. The large number of ly6𝑐 ℎ𝑖𝑔ℎ
monocytes may simply arrive in the ovary before ovulation occurs simply to serve as a
source of both types of macrophages, since they are versatile and can become either one
based on cellular cues in the tissue environment they infiltrate. The population of
ly6𝑐 ℎ𝑖𝑔ℎ cells is transient, as these are short lived cells that down-regulate ly6c
expression quickly and differentiate into macrophages27,31.
Two cell types that do not seem to be playing a role in ovulation are the dendritic
cells and T cells. Cells that stained positive for CD11c are generally accepted to be
dendritic cells, and cells that stain positive for CD3 are T cells. From our results,
absolute numbers of dendritic cells and T cells in the ovaries do not seem to be increasing
or decreasing. This would suggest that they likely are not playing a major role in
ovulation. It is logical that T cells would not play a role because they are involved in
acquired immunity, and ovulation is a naturally occurring process with no foreign
particles involved. However, other studies have indicated the presence of T cells in the

57

ovaries during corpus luteum development, so more studies should be done to determine
their role.
The M2-like macrophages were designated as CD206+ cells. These cells did not
really exhibit any significant pattern or trend in our results. If anything, it looks as if
there may have been an increase in M2-like macrophages after the resolution of ovulation
at hCG 20hr. This would make sense because these macrophages tend to help repair
tissue and clean up cellular debris left behind from other cells. These assays should be
repeated with a more specific antibody, however, as the antibody used for CD206 did not
demonstrate sufficient effectiveness. This may have been due to low CD206 expression
or some other reason, but it made it difficult to differentiate M2-like macrophages from
other cell types. Therefore it is advisable to repeat the flow cytometry assays to better
identify this population of cells.
M1-like macrophages were designated as double positive for CD197 and IA. The
results show an increase in these cells during ovulation. As these are inflammatory in
nature, this seems probable. However, as seen with the CD206 antibody, the CD197
antibody did not produce good results, making it hard to differentiate M1-like
macrophages from other populations. This may also have been because of low CD197
expression. This population should also be better differentiated, perhaps by using a
different antibody or by searching for a different unique M1 macrophage antigen.
Any cells that stained positive for ly6g were designated as neutrophils.
According to our results, it appears that neutrophils doubled in number throughout
ovulation. Neutrophils are part of the innate immune system and are highly
inflammatory, so it would make sense that they would be involved in ovulation. They
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could potentially be helping follicles rupture by releasing inflammatory cytokines to
degrade the follicular wall until the oocyte is released. Others suggest that neutrophils
may be recruited to the ovary by other leukocytes, possibly by monocytes.
We also used a general marker for macrophages, called F4/80, to identify them in
the ovary. Our results, although not significant, show that after administering hCG,
F4/80 positive cells double in absolute number in the ovary. These would include both
M1-like macrophages, for promoting inflammation and follicular rupture, and M2-like
macrophages, for repairing tissue and bringing ovarian tissue back to the start of the
ovulatory process. The numbers for generic macrophages remain high throughout
ovulation because both M1 and M2 populations play important roles and are active at
different points throughout ovulation.
The spleen is a known lymphoid organ, and in our case, may act as a source of
cell donation for the ovaries. Our results show immature control mice having many more
leukocytes in their spleen than mice taken during ovulation. The spleen, just as it donates
white blood cells to a site of injury, may also be donating some leukocytes to the ovaries
and other reproductive tissues to help the process of ovulation occur. This is probably
due to the fact that ovulation requires inflammatory factors to occur and reparative
factors to help restore tissue after ovulation occurs.
Counting cumulous oocyte complexes (COCs) proved to be a challenging task, as
each pair of ampullas had to be separated from the ovaries in a delicate manner so as not
to tear the ampullas and lose any COCs. This process was made significantly easier by
using fine scissors and tweezers, which could make precise cuts without tearing the
ovaries or ampullas. The complexes are also very mucous-like and tend to stick to each
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other, making it difficult to count. However, there was a distinct bulge in every ampulla
that actually held all the COCs, making them easier to locate. If the distinct bulge was
not present on the ampulla, it usually meant no or very few COCs would be found.
Overall, the results for ovulation rates ranged between 14 and 29 COCs. Lower ovulation
rates usually had one mouse that did not have distinctive ampulla bulges, causing the
average to be reduced. These ovulation rates are a good basis for future experiments
investigating the effect of specific compounds on ovulation. For instance, we would
expect lowered ovulation rates from mice that were given a drug that would stop the
activity of luteinizing hormone.
When I began this project, I used one panel of antibodies for flow cytometry,
which was designed for isolating ly6𝑐 ℎ𝑖𝑔ℎ and ly6𝑐 𝑙𝑜𝑤 monocytes, and
CD11c+/IA+/F480+ cells, which would have included macrophages and dendritic cells.
After learning the basics of flow cytometry, I designed new panels that were designed to
isolate macrophages, and later narrowed it down to a panel for M1-like macrophages and
a panel for M2-like macrophages. However, there was one antibody from each of these
panels that was very inefficient, and therefore we could never obtain conclusive results
on these macrophages. The M1 panel antibody that did not work well was CD197, and
the M2 panel antibody was CD206. It is likely that CD197 is not significantly expressed,
which made it difficult to isolate from other cell types. The antibody for CD206 is for a
receptor that is found inside the cell, so we utilized intracellular staining. Again, we were
unable to effectively identify M2-like cells from other cell types. Other flow markers for
M2-like macrophages that may potentially work better for future panels include CD64
and MerTK34.
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Our immunohistochemistry experiments were more recent attempts to identify the
cells, and were not fully completed. We were only able to successfully stain a few
leukocyte markers. We used formalin fixed tissues, which creates problems by masking
our antigens, making them not accessible to antibodies. Another possible problem may
have been due to our use of a microwave to heat the tissue before we stained, which may
have denatured our antigens beyond antibody recognition.
Future Aims
One of the first priorties is to complete the immunohistochemistry assays. We
must first identify useful antibodies to stain specific white blood cells using the spleen
tissue as a control, and then progress to ovarian tissue to identify where in the ovary these
cells were going. This will help to elucidate the location of the cells infiltrating the
ovary, as flow cytometry only indicates how many were entering. Without knowing
where these cell types are located in the ovary, it is harder to say with certainty what their
function is. After we are able to identify where these cells are going, it would also be of
interest to stain for specific cytokines and chemokines, particularly those that are
inflammatory in ovarian tissue, taken before and during ovulation, or cytokines that are
able to mend tissue in ovary sections taken after ovulation is over. This would further
clarify the function of many of these cells.
It may also be informative to use cell cultures of ovarian tissue to test for cytokine
and chemokine production. After getting an idea of baseline production, the addition of
specific leukocyte populations should cause increased production of particular cytokines
and chemokines. It may be interesting to see how 𝑙𝑦6𝑐ℎ𝑖𝑔ℎ monocytes affect cytokine
production. As an alternative, cell growth could be altered in response to particular
61

cytokines and chemokines, supporting the idea that leukocytes are promoting tissue
remodeling after ovulation. Cell culture could provide new insight into chemokine
activities during ovulation.
Another project would be to search for a better marker to use for the M1 and M2like panels. RT-PCR could also be used to identify M1- and M2-like macrophages in the
ovaries, since there are not very efficient antibody markers available. RT-PCR would be
able to quantify levels of mRNA using macrophage markers that are not as easily
detected via flow cytometry.
Together with narrowing down macrophage involvement, we could perform more
experiments looking for neutrophils and determining their role in ovulation. Designing a
flow panel to identify them is easily manageable and since they are an innate white blood
cell, they appear to be a good candidate for playing a role in ovulation as well. Ovulation
is naturally occurring so it would make sense that these innate cells, which are
inflammatory cells, might be involved at some level. Furthermore, many studies have
also been able to determine that neutrophils do appear in the ovary, particularly around
the basement membrane of mature follicles. As monocytes have been shown to be able
to regulate neutrophil activity in response to commensals and their products, it would be
of interest to discern whether they also regulate neutrophils in ovarian tissue37.
Further studies should be conducted on the effect of estrogen on ovulation.
Estrogen is generally regarded to be an anti-inflammatory hormone and is highly
involved in the process of ovulation. Estrogen levels remain elevated prior to ovulation,
and once they drop, ovulation is able to occur. An influx of leukocytes is also seen after
estrogen levels drop, coinciding with ovulation. This suggests that estrogen acts as one
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of the key signals for leukocyte recruitment. Preliminary experiments administering
estradiol to mice were performed following super ovulation, but more experiments need
to be done to determine the precise effect it had on leukocyte infiltration. Along with this
aspect, it would be ideal to see the effect of estradiol inhibitors on ovulation. For
instance, estrogen inhibitors should block the anti-inflammatory effect of estrogen,
potentially allowing leukocytes to enter prematurely in the ovary. This would no doubt
have an effect on ovulation success, possibly causing premature follicle rupture.
It would also be a good idea to see the effect that administering leukocyte
inhibitors has on ovulation. If leukocytes are truly are involved in helping ovulation
occur, then blocking their migration to the ovary should effectively reduce the ability to
ovulate. This should be easy to discern by looking to see whether ovarian cell counts
increase after ovulation, and by checking ovulation rate by counting COCs. If cell counts
remain low and similar to control mice, and ovulation rates are low, it would effectively
support the role leukocytes have in ovulation. Inhibitors for monocytes and neutrophils
would be a great starting point for this idea, specifically looking at inhibitors for CCR2,
which is a major chemokine found on monocytes. INCB3344 is a drug that has been
shown to be an effective and efficient antagonist for blocking monocyte recruitment.
This drug can be administered orally to mice and binds to CCR2 on monocytes,
effectively inhibiting monocyte extravasation46,47. A drug candidate for blocking
fractalkine and ly6𝑐 𝑙𝑜𝑤 monocytes is AZ1220118239,43. This particular drug is specific to
the receptor C𝑋3 𝐶𝑅1 and can inhibit the pro-survival effects of fractalkine and also block
mRNA production of epiregulin43. An option for inhibiting neutrophil infiltration is the
drug DF 2156A, which is a potent, non-competitive, allosteric inhibitor for both the
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CXCR1 and CXCR2 receptors45. It is important to note that by blocking one type of
leukocyte, the lack of that particular cell’s influence and products could indirectly cause
decreased recruitment of other white blood cells.
Due to chemokine redundancy, leukocytes may still be recruited to tissue using
other routes, so an alternative to merely blocking chemokines and their receptors would
be to use knockout mice that do not express the chemokine receptors at all. To test how
important monocytes in particular are to ovulation, running the same experiments on
CCR2 knockout mice would be advantageous. These mice should have normal numbers
of white blood cells, but monocytes and macrophages would not express CCR2, making
them much less likely to be recruited to tissue36. Monocyte infiltration into the ovary
should be reduced, and in theory would result in reduced ovulation rate.
In summary, we were able to positively identify the presence of numerous
leukocytes in the ovaries, including monocytes, macrophages, and neutrophils. We were
able to narrow down specifically 𝑙𝑦6𝑐 ℎ𝑖𝑔ℎ monocyte infiltration as occurring before
ovulation, supporting the notion that these inflammatory leukocytes promote degradation
of the basement membrane of the follicle. We were also able to correlate influx of
leukocytes in the ovary to a decreased number in the spleen, suggesting the spleen as a
source for additional leukocytes. The presence of these white blood cells in the ovaries
supports the need for leukocyte involvement in successful ovulation. Reproductive
immunology, although a fairly recent field of study, proves to be a promising approach to
determining means to help increase fertility in women who have a variety of either
reproductive or immune diseases. The results substantiate this idea and suggest that
novel therapies could be developed based on the immune response.
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Appendix A:
Immunohistochemistry Results
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Figure 27. Tissue from spleen and ovary stained with B220.
Splenic tissue (left) stained positive for the antibody B220, indicating the presence of B cells.
Ovarian tissue (right) did not stain positive for the antibody B220, indicating no B cells were
present.

Figure 28. Additional H&E stained tissue.
Ovarian tissue (left) and oviduct tissue (right) stained with hematoxylin and eosin. The arrow
points out a follicle in the ovarian tissue.
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Figure 29. Leukocyte infiltration into ovaries.
Estrogen is causing an increase in leukocyte infiltration compared to the same groups that did
not receive estrogen. For percentage, group hCG 20 plus estrogen was significantly different
from groups control, PMSG 48hr, and hCG 12hr. The group hCG 20hr plus estrogen was also
significantly different from the control group for absolute numbers. Different letters show
significant difference. Results represent mean ± SEM of n=3 mice and are representative of 3
experiments (p<0.05, ANOVA + Tukey).
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